ARKG position history
The shares of ARK Genomic Revolution ETF (ARKG) that ARK Investment Management LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2021 Q3: 15,912 shares, $1.2M, <0.01% of portfolio
- 2021 Q4: 53,390 shares, $3.3M, <0.01% of portfolio, Add +235.5%
- 2022 Q1: 6,849 shares, $315K, <0.01% of portfolio, Reduce −87.2%
- 2022 Q2: 10,707 shares, $345K, <0.01% of portfolio, Add +56.3%
- 2022 Q3: 1,581 shares, $52K, <0.01% of portfolio, Reduce −85.2%
- 2022 Q4: 16,134 shares, $455K, <0.01% of portfolio, Add +920.5%
- 2023 Q1: 6,032 shares, $181K, <0.01% of portfolio, Reduce −62.6%
- 2023 Q2: 3,195 shares, $109K, <0.01% of portfolio, Reduce −47.0%
- 2023 Q3: 4,024 shares, $112K, <0.01% of portfolio, Add +25.9%
- 2023 Q4: 9,179 shares, $301K, <0.01% of portfolio, Add +128.1%
- 2024 Q1: 8,117 shares, $233K, <0.01% of portfolio, Reduce −11.6%
- 2024 Q2: 7,340 shares, $172K, <0.01% of portfolio, Reduce −9.6%
- 2024 Q3: 3,468 shares, $89K, <0.01% of portfolio, Reduce −52.8%
- 2024 Q4: 5,989 shares, $141K, <0.01% of portfolio, Add +72.7%
- 2025 Q1: 3,892 shares, $81K, <0.01% of portfolio, Reduce −35.0%
- 2025 Q2: 4,321 shares, $105K, <0.01% of portfolio, Add +11.0%
- 2025 Q3: 7,051 shares, $196K, <0.01% of portfolio, Add +63.2%
- 2025 Q4: 5,029 shares, $146K, <0.01% of portfolio, Reduce −28.7%
- 2026 Q1: 6,773 shares, $179K, <0.01% of portfolio, Add +34.7%
- 2026 Q2: 1,659 shares, $70K, <0.01% of portfolio, Reduce −75.5%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|